Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-05-02 00:00:00 ET · period of report 2024-05-01 · accession 0001510281-24-000270 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-05-02 | 2024-05-01+ | HQL | Saba Capital Management, L.P. | 10% | P - Purchase | $13.46 | +26.5K | 3.07M | +0.9% | +$356.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-01 | P | A | 252 | $13.02 | 3,042,456 | I - | — | — | |
| 2 | Common | Common Stock | 2024-05-02 | P | A | 26,274 | $13.46 | 3,068,730 | I - | — | — |